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Subcostal Anterior Quadratus Lumborum Block Versus
Epidural Block for Analgesia in Open Nephrectomy:
A Randomized Clinical Trial
Hesham Elsharkawy, MD, MBA, MSc, FASA,*† Sanchit Ahuja, MD,†‡ Daniel I. Sessler, MD,†
Kamal Maheshwari MD, MPH,†§ Guangmei Mao, PhD, MPH,†∥ Wael Ali Sakr Esa, MD, MBA, PhD,§
Loran Mounir Soliman, MD,§ Sabry Ayad, MD, MBA, FASA,† Dilara Khoshknabi, MD,†
Mohammad Zafeer Khan, MD,¶ Syed Raza, BS,† Sean DeGrande, MD,#
and Alparslan Turan, MD†§
BACKGROUND: Epidural block are often used for analgesia after open nephrectomy surgery.
Subcostal anterior quadratus lumborum block may be an alternative. We therefore tested the
hypothesis that the continuous subcostal anterior quadratus lumborum block is noninferior to
epidural block for analgesia in patients having open partial nephrectomies.
METHODS: Adults having open partial nephrectomies were randomly allocated to epidural or
unilateral subcostal anterior quadratus lumborum block. The joint primary outcomes were opioid consumption measured in morphine equivalents and pain measured on a numeric rating
scale (0–10) from postanesthesia care unit (PACU) until 72 hours after surgery. The noninferiority deltas were 30% for opioid consumption and 1 point on a 0–10 scale for pain. Secondary
outcomes included patient global assessment of pain management on the third postoperative
day, the number of antiemetic medication doses through the third postoperative day, duration of
PACU stay, and postoperative duration of hospitalization.
RESULTS: Twenty-six patients were randomized to anterior quadratus lumborum block and 29
to epidural analgesia. Neither pain scores nor opioid consumption in the quadratus lumborum
patients were noninferior to epidural analgesia. At 72 hours, mean ± standard deviation pain
scores in subcoastal anterior quadratus lumborum block and epidural group were 4.7 ± 1.8
and 4.1 ± 1.7, with an estimated difference in pain scores of 0.62 (95% confidence interval
[CI], 0.74-1.99; noninferiority P = .21). The median [Q1, Q3] opioid consumption was more
than doubled in quadratus lumborum patients at 70 mg [43, 125] versus 30 mg [18, 75] in the
epidural group with an estimated ratio of geometric means of 1.69 (95% CI, 0.66-4.33; noninferiority P = .80). Patient global assessment and duration of PACU and hospital stays did not
differ significantly in the 2 groups.
CONCLUSIONS: We were unable to show that subcostal anterior quadratus lumborum block are
noninferior to epidural analgesia in terms of pain scores and opioid consumption for open partial nephrectomies. Effectiveness of novel blocks should be rigorously tested in specific surgical
setting before widespread adoption. (Anesth Analg 2021;132:1138–45)

KEY POINTS
• Question: Is continuous subcostal anterior quadratus lumborum block noninferior to epidural
block in terms of pain score and opioid consumption among patients undergoing open partial
nephrectomy?
• Findings: Neither pain scores nor opioid consumption in the subcostal anterior quadratus
lumborum group were noninferior to epidural analgesia.
• Meaning: We were unable to show that subcostal anterior quadratus lumborum block are
noninferior to epidural analgesia for reducing pain scores and opioid consumption for open
partial nephrectomies.
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GLOSSARY
ASA = American Society of Anesthesiologists; BMI = body mass index; CABG = coronary artery
bypass graft; CI = confidence interval; CONSORT = Consolidated Standards of Reporting Trials; Nmiss =
the number of missing; NI = noninferiority; NI-P = noninferiority P value; ORSDS = Opioid-Related
Symptom Distress Scale; PACU = postanesthesia care unit; POD = postoperative day; QL = quadratus lumborum; QoR = quality of recovery; SD = standard deviation; TWA = time-weighted average

O

pen nephrectomies cause substantial postoperative pain. Thoracic epidural analgesia is
generally considered the best analgesia for
abdominal wall surgeries, but use in renal surgery
is limited due to hypotension and because it precludes use of postoperative anticoagulants which are
often indicated.1,2 Analgesic management in patients
recovering from renal surgery therefore remains challenging and often depends on opioids despite their
well-known limitations and risks.3
Recently developed truncal interfascial blocks such
as the quadratus lumborum (QL) block may reduce
pain after open renal surgery.4,5 Compared to thoracic
epidural analgesia, QL blocks do not cause a generalized lower body sympathectomy, and thus do not
promote hypotension. Furthermore, the block is relatively safe even when patients are anticoagulated.5
Various local anesthetic injection sites have been
described for QL blocks, and the injection site determines which dermatomes are covered.6 But injecting
local anesthetic anterior to QL muscle presumably
allows drug to spread into the thoracic paravertebral
space, thereby blocking the somatic and thoracic sympathetic trunk of lower thoracic segments.6–9 Using a
subcostal anterior approach appears to extend dermatomal coverage based on a cadaver study.10 In a pilot
series of 22 patients, we observed T6-L2 dermatomal
coverage that should be suitable for subcostal nephrectomy incisions.9 However, it remains unknown
whether subcostal anterior QL block provide analgesia
comparable to thoracic epidural block. We therefore
tested the hypothesis that subcostal anterior QL block
with a continuous catheter are noninferior to epidural
analgesia on pain control and opioid consumption in
patients having open partial nephrectomy.
METHODS
The trial was approved by the Cleveland Clinic
Institutional Review Board (IRB #15-1291). The study
was registered at Clinical Trials.gov (NCT03110081;
principal investigator: Hesham Elsharkawy; date:
December 22, 2016) before the first patient was
enrolled. This study followed good clinical practice
quality standards and ethical guidelines described
by the Declaration of Helsinki.11 Written informed
consent was obtained from all participating patients.
This article adheres to the applicable Consolidated
Standards of Reporting Trials (CONSORT) guidelines.
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We included adults aged ≥18 years, who were
scheduled for elective open unilateral partial nephrectomy surgery at Cleveland Clinic Main Campus and
Fairview Hospital. Patients were excluded if they had
intolerance or allergy to opioids, were pregnant, had
contraindications to epidural analgesia or QL block, or
had chronic pain characterized by opioid use for >30
consecutive days within the 3 preoperative months at
a dose equivalent to at least 15 mg of morphine.12
Patients were randomized 1:1, stratified by trial
site, to either a unilateral subcostal anterior QL catheter or an epidural catheter. Randomization was
based on computer-generated random allocation
sequences with random block sizes. Allocations were
maintained on a secure website that was accessed just
before performance of the procedure. Allocation was
thus concealed to the extent practical.
Both epidural blocks and subcostal anterior QL
blocks were performed by faculty anesthesiologists
who had served on the acute pain management service
for at least 4 years and had performed at least 40 QL
blocks. Blocks were deemed failures if the expected
dermatomal coverage was not apparent. Catheters
were then repositioned or removed and reinserted.
We used a previously described approach to subcostal anterior QL block.9 In summary, the patients
were positioned lateral decubitus. A curvilinear
2–5 MHz ultrasound transducer (SonoSite S-Nerve,
Bothell, WA) was positioned posteriorly below the
12th rib in a parasagittal oblique plane at L1-2 level.
The QL muscle was visualized and its point of insertion on the 12th rib identified. An 18-gauge Tuohy
needle was advanced in the caudal-to-cranial direction between QL muscle and the psoas major muscle
until a click could often be felt as the needle tip penetrated the anterior investing fascia of the QL muscle.
After a negative aspiration, 20 mL of 0.25% bupivacaine was injected through the needle to help confirm
the final needle tip position, anterior to the QL muscle
at close proximity to the 12th rib.
Thereafter, a 19-gauge peripheral nerve catheter
(InfiltraLong Catheter, PAJUNK, Geisingen, Germany)
was advanced 2–4 cm past the needle tip. Five milliliters
of bupivacaine 0.25% was injected through the catheter
to ensure catheter location. The catheter was tunneled
medially then secured by transparent dressing and an
ambulatory electronic infusion pump (Moog Curlin
Infusion Pump, Salt Lake City, UT) was attached to the
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catheter. An infusion of ropivacaine 0.2% was started
towards the end of surgery in the operating room at
a rate of 8 mL/h. Postoperatively, a continuous infusion of ropivacaine 0.2% was given through the catheter at a basal rate of 8 mL/h with patient-controlled,
on-demand boluses of 6 mL allowed every 30 minutes.
The infusion continued for at least 48 hours, and longer
if deemed necessary by the acute pain team.
Patients assigned to epidural analgesia had midthoracic catheters inserted preoperatively at T7-8,
guided by anatomical surface landmarks. A 17-gauge
Tuohy needle was inserted either midline or paramedian, and the epidural space was identified by lossof-resistance to saline. The catheter was threaded
through the needle and advanced 2–4 cm past the
needle tip. The catheter position was tested by injecting 3 mL of a mixture of lidocaine 1.5% and epinephrine 1:200,000 through the catheter. The epidural
catheter was secured by transparent dressing and an
ambulatory electronic infusion pump was attached to
the catheter hub.
An infusion of bupivacaine 0.1% was started
towards the end of surgery in the operating room at
an infusion rate of 5 mL/h, and continuously administered for at least 48 hours and longer if deemed
necessary by the acute pain team. Patient-controlled
epidural boluses of 6 mL every 30 minutes were permitted. Local anesthetic was infused through both the
peripheral nerve catheter and epidural catheter at the
end of the surgery and in the postoperative period
via an ambulatory electronic infusion pump (Moog
Curlin Infusion Pump).
Clinicians performing the blocks and patients
were not blinded, but investigators evaluating the
outcomes were blinded to randomization. Bandages
were positioned over the catheter and the infusion
pump such that it was not obvious which block
patients were assigned to. Similarly, control panels for
the infusion pumps and the drug bags were covered
to blind investigators evaluating outcomes.
All patients received general volatile anesthesia for
surgery per institutional routine. Only fentanyl was
permitted intraoperatively. Wound infiltration with
local anesthetics and nonsteroidal anti-inflammatory
medications were not permitted. In the postanesthesia care unit (PACU), patients were given intravenous
boluses of opioids as needed according to the surgical
and pain teams.
Patients in both groups received an intravenous
patient-controlled analgesia system for rescue analgesia
if needed. The intravenous patient-controlled analgesia
system was provided with fentanyl boluses of 25 µg at
6-minute intervals without a basal infusion. Patients
were also given intravenous boluses of fentanyl
(25–50 µg) or hydromorphone (0.2–0.4 mg) for breakthrough pain if needed. Patients were given 1000 mg of
1140   
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intravenous acetaminophen in the PACU, followed by
1000 g oral acetaminophen 3 times daily for 48 hours.
Measurements
Baseline characteristics, including age, sex, race,
and body mass index were retrieved from electronic
medical records. Medical history, American Society
of Anesthesiologists physical status, duration of
surgery, and smoking status were recorded by the
investigators.
The primary outcomes were opioid consumption
and pain scores in the first 72 postoperative hours.
Total opioid consumption was estimated as intravenous morphine equivalents.13 Pain scores, based on
nursing assessments on a numeric pain rating scale
(0–10, with 10 being worst) were recorded at 4-hour
intervals and summarized as time-weighted average
value by trapezoidal method.
We recorded the quality of recovery (QoR)-15 score
and patient global assessment of pain management on
the third postoperative day, along with the total number of antiemetic medication doses through the third
postoperative day. Duration in the PACU stay and of
postoperative hospitalization were also recorded.14–17
Safety and quality outcomes included 2 components: (1) adverse events related to opioid use measured with the Opioid-Related Symptom Distress
Scale18 and (2) a collapsed composite of postoperative
oxygen administration, naloxone administration, and
discontinuation of the local anesthetic infusion within
72 hours due to hypotension or weakness interfering
with physical therapy or mobility.
On an exploratory basis, a blinded investigator
assessed the dermatomal sensory level ipsilateral to
the surgical incision using ice on postoperative days
1–3. We also quantified ward hypotensive episodes
through discharge, defined by mean arterial pressure <65 mm Hg, as measured by nurses at 4-hour
intervals.
Statistical Analysis
We assessed balance of the randomized groups on
baseline and procedural characteristics using absolute standardized difference, defined as the absolute
difference in mean values, mean ranks, or proportions divided by the pooled standard deviation (SD).
Baseline variables with absolute standardized

1
1 
+  were considered
difference >0.53  ie, 1.96 ×
n1 n 2 

imbalanced.
In the primary analysis, we assessed noninferiority
of QL catheters to epidural analgesia on pain scores
and total intravenous morphine equivalent doses of
rescue opioid (after a logarithmic transformation)
until the third postoperative day with 1-tailed noninferiority t tests. Noninferiority was tested using the
ANESTHESIA & ANALGESIA

Copyright © 2021 International Anesthesia Research Society. Unauthorized reproduction of this article is prohibited.

E  Original Clinical Research Report
confidence interval (CI) method, defined as not >30%
higher in opioid consumption and not >1 point worse
in pain score. Specifically, noninferiority would be
claimed if the upper limit of the 95% 2-sided (corresponds to α of .025 on upper tail) CI for the ratio of
geometric mean values of total opioid consumption
was less than the noninferiority delta of 1.3, and for
the difference in mean values of pain score was less
than the noninferiority delta of 1 point. P values were
obtained from a 1-tailed t test using a test statistic
β1 − δ
defined as TNI =
, where β1 is the estimated treatSEβ
ment effect, SEβ is the standard error of the treatment
effect, and δ is the noninferiority delta. The overall
significance level for noninferiority is .025 and the significance criterion for each test is also .025. In this joint
hypothesis testing scenario, no adjustment for tests on
2 outcomes was needed because both outcomes are
required to be significant to claim that QL is noninferior (ie, this is an intersection-union test).19
Analyses were modified intent-to-treat and thus
included all randomized patients who received some
amount of study intervention. We planned 3 interim
analyses to assess efficacy and futility of the primary
outcome at every 25% of the planned enrollment using
a group sequential design with a gamma-spending
function (γ = −4 for efficacy and −2 for futility) and
nonbinding futility boundaries. The overall significance level was maintained at .025 across the interim
monitoring. At the secondary interim, the P value
boundaries were P < .0024 for efficacy and P ≥ .36 for
futility for the primary outcomes. CIs for the primary
outcomes are thus estimated using the z-statistic corresponding to the significance criterion at the second
interim, making them 99.76% CIs. However, we refer
to them as “95% CI” throughout since the 1-sided
alpha level for the study was .025.
We compared the randomized groups for each secondary outcome using appropriate 2-tailed tests for
superiority. Specifically, patient global assessment
was compared using Wilcoxon rank sum tests. Any
antiemetic medications and any episodes of hypotension were assessed using logistic regression. Length of
hospital stay and PACU stay was assessed using linear
regression. The significance level for the set of secondary outcomes is preserved at .05 overall using a criterion
of P < .05/5 = .01 for each test (applying a Bonferroni
correction for multiple testing of the 5 secondary outcomes). We used SAS version 9.4 for the analyses.
1

1

Sample Size and Power
Sample size was based on being able to detect noninferiority on both total opioid consumption and pain
score in the first 72 hours with about 85% overall
power at the overall .025 significance level. Based on
pilot data, we assume that QL block provides equal
April 2021 • Volume 132 • Number 4

efficacy compared to epidural; time-weighted average pain scores have a mean of about 4 with a SD of
1.5; the opioid consumption with a coefficient of variation (SD/mean) of 0.45. For a single-analysis study,
we would need about 100 patients to detect noninferiority for opioid consumption at the .025 significance
level, assuming noninferiority delta of 1.3 in ratio of
geometric means (ie, 30% increase in opioid consumption). At the same time, a total of 100 patients would
give over 90% power to detect noninferiority in pain
score with a delta of 1 point.
RESULTS
We enrolled patients from May 2017 to February 2019
at the Cleveland Clinic Main Campus and Cleveland
Clinic Fairview Hospital. The second interim analysis
was conducted after 50% of the planned patients were
enrolled. Because futility boundaries (P ≥ .36) were
crossed at that time, the study was concluded per protocol after enrollment of 55 patients. No patient withdrew from this study, thus we included all of them in
the analyses. A total of 26 patients were randomized
to QL blocks and 29 to epidural analgesia (Figure 1).
The absolute standardized difference of all potentially
confounding baseline and procedural characteristics
were within 0.53, so we did not adjust for any confounders in all analyses (Table 1). Dermatomal sensory block levels are shown in Figure 2.
Time-weighted average pain scores and total opioid consumption in the first 72 hours after surgery
are summarized by treatment group in Table 2 and
Figure 3. Mean ± SD pain scores in subcoastal anterior
QL block and epidural group were 4.7 ± 1.8 and 4.1 ±
1.7, with an estimated difference in pain scores of 0.62
(95% CI, 0.74-1.99; noninferiority P = .21). The median
[Q1, Q3] opioid consumption was more than doubled
in QL patients at 70 mg [43, 125] versus 30 mg [18, 75]
in the epidural group with an estimated ratio of geometric means of 1.69 (95% CI, 0.66-4.33; noninferiority
P = .80).
The secondary outcomes are summarized in
Table 3. Length of PACU stay, length of hospital stays,
QoR-15 score, the incidence of postoperative antiemetic medication, and patient global assessment on
postoperative day 3 did not differ significantly in the
QL and epidural groups. Safety and quality outcomes
were summarized in Table 3. There were no clinically
meaningful differences between the groups.
DISCUSSION
The trial was stopped per protocol at a planned
interim analysis on the basis of futility. Specifically,
the results were inconsistent with our hypothesis that
subcostal QL block are noninferior to epidural analgesia on pain and opioid consumption. No significant difference in pain scores were noted with each
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Figure 1. Flow chart. QL indicates
quadratus lumborum.

Table 1. Patient Characteristics (N = 55)
Factor
Demographics
Age (y)
Sex (female versus male)
BMI (kg/m2)
Race
  White
  Black
  Other
ASA physical status
  II
  III
  IV
Medical history
Obstructive sleep apnea
Diabetes mellitus
Myocardial infarction
Ischemic heart disease
(angina/stent/CABG)
Chronic pain requiring opioids
Current smoker
Cancer
Duration of surgery (h)
Length of PACU stay (h)
Length of hospital stay (d)

QL
(N = 26)

Epidural
(N = 29)

Standardized
difference

63 ± 10
14 (54)
33 ± 8

65 ± 12
9 (31)
33 ± 7

−0.17
0.47
0.02
0.05

22 (85)
3 (12)
1 (4)

25 (86)
3 (10)
1 (3)

2 (8)
22 (85)
2 (8)

1 (3)
24 (83)
4 (14)

0.26

6
7
5
2

(23)
(27)
(19)
(8)

4
5
2
6

(14)
(17)
(7)
(21)

0 (0)
2 (7)
2 (8)
5 (17)
17 (65)
13 (45)
5.3 ± 1.3 5.5 ± 0.9
2.2 ± 1.0 2.2 ± 0.9
5.0 ± 1.3 5.3 ± 1.4

0.24
0.24
0.37
−0.38
−0.38
−0.29
0.42
−0.26
−0.01
−0.15

Summary statistics are presented as mean scores ± standard deviations
or N (column %).
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass
index; CABG, coronary artery bypass graft; PACU, postanesthesia care unit;
QL, quadratus lumborum.

approach as is typical in such trials because patients
use patient-controlled opioids to suitably block surgical pain. In contrast, patients randomized to QL
blocks used more than twice as much opioid as those
given epidural analgesia.
Our results contrast with 2 similar trials comparing QL block and epidural analgesia for nephrectomy
1142   
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surgery.20,21 However, both restricted enrollment to
patients having laparoscopic procedures whereas all
our patients had open surgery, which is more painful.
Furthermore, open nephrectomy incisions involve
anterolateral abdominal wall innervation by T6-T12
thoracolumbar spinal nerves.22 The pain originating
from kidney reaches the lower thoracic spinal cord via
celiac and renal plexus, greater and lesser splanchnic
nerves, and sympathetic and parasympathetic trunks
with nerve root innervation from T4-L1.23,24 Adequate
visceral coverage therefore requires blocks reaching
to T4. Although cadaver studies indicate that injected
contrast can spread cranially through the thoracic
paravertebral space to T4, the actual extent of sensory
dermatomal coverage in our QL patients was less and
inconsistent, ranging from T6 to L2.8,10 In contrast,
epidural blocks were more consistent and had wider
dermatomal coverage, ranging from T4 to L2.
An additional factor is that open nephrectomy incisions often extend to the midline, an area better covered by the bilateral analgesia of epidural block.24 And
finally, visceral postoperative pain may also be better
covered by epidural block. There are thus various reasons that epidural analgesia is preferable to QL block
for open nephrectomy surgery—although previous
work suggests that the block are suitable for laparoscopic nephrectomies. There was no significant difference in PACU duration and overall length of hospital
stay in patients randomized to QL or epidural blocks,
presumably because no evidence for a difference in
pain scores was observed.
Our trial did not demonstrate reduced postoperative nausea and vomiting in the QL group.
Midthoracic epidural effectively blocks sympathetic
ANESTHESIA & ANALGESIA
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Figure 2. Dermatome coverage
on PODs 1–3. PODs indicates
postoperative days; QL, quadratus lumborum.

Table 2. Primary Outcome Analysis: Comparison Between QL Block and Epidural Analgesia on Pain Score
and Opioid Consumption From the Time of Arrival to PACU until 72 h After Surgery
QL
(N = 26)

Epidural
(N = 29)

4.7 ± 1.8

4.1 ± 1.7

70 [43, 125]

30 [18, 75]

NI delta

Pain score, mean ± SDc
Opioid consumption in mg,
median [Q1, Q3]d

1
1.3

Effect size (95% CI)a
Difference in mean values (QL − epidural)
0.62 (−0.74 to 1.99)
Ratio of geometric mean values (QL/epidural)
1.69 (0.66-4.33)

NI-Pb
.21
.80

Abbreviations: CI, confidence interval; NI, noninferiority; NI-P, noninferiority P value; PACU, postanesthesia care unit; QL, quadratus lumborum block; SD, standard
deviation.
a
95% CI was adjusted for sequential design. We would claim NI if upper limit of 95% 2-sided CI < NI delta. They are called “95% CI” here and throughout since
the 1-sided alpha level for the study was .025, even though the actual CIs at the second interim analysis were 99.8% using the efficacy boundary of P < .0024.
b
Significant if P < .0024.
c
Summary statistics of pain scores are reported as mean ± SD of time-weighted average pain during the first 72 h. Difference in time-weighted average pain
scores was assessed in a linear regression model.
d
Total opioid consumption (milligrams as intravenous morphine equivalent) in the first 72 h after surgery was summarized as median [Q1, Q3]. Difference of opioid
consumption between 2 groups was assessed using a linear regression model after logarithm transformation of opioid consumption.

Figure 3. Pain and opioid consumption. Left panel
shows the TWA of pain score in the first 72 h after
surgery. Right panel shows the cumulative opioid
consumption as intravenous morphine equivalent
in the first 72 h after surgery (y-axis is on log
scale). The whiskers are the 2 lines outside the
box that extend to the highest and lowest observations. QL indicates quadratus lumborum; TWA,
time-weighted average.
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Table 3. Comparison Between QL Block and Epidural Analgesia on Secondary, Safety, and Exploratory
Outcomes
Nmiss
Secondary outcomesa
Length of PACU stay (h)b
Length of hospital stay (d)b
QoR-15 scoreb
Any antiemetic medicationc
Patient global assessmentd
  Poor
  Fair
  Good
  Excellent
Safety and quality outcomese
ORSDSb
  POD 1
  POD 2
  POD 3
Any hypotensionc
Collapsed composite of postoperative oxygen
administration, naloxone administration,
and stopping of local anesthetic infusionc

0
0
1
1
1

QL (N = 26)
Summary
2.2 ± 1.0
5.0 ± 1.3
109 ± 19
3 (12%)

Epidural (N = 29)
Nmiss
Summary
1
0
0
0
1

3 (12%)
8 (32%)
11 (44%)
3 (12%)

1
1
1
1
1
1

0.44 ± 0.26
0.49 ± 0.31
0.53 ± 0.33
0.30 ± 0.30
5 (20%)
15 (60%)

2.2 ± 0.9
5.3 ± 1.4
102 ± 21
8 (28%)

Effect size
(99% CI)
0.1 (−0.6, 0.8)
−0.2 (−1.2, 0.7)
7.2 (−7.4, 22)
0.4 (0.04, 2.2)

P
.81
.54
.19
.16
.63

5 (18%)
7 (25%)
8 (29%)
8 (29%)

0
0
0
1
0
0

0.49 ± 0.28
0.54 ± 0.44
0.48 ± 0.36
0.45 ± 0.37
4 (14%)
14 (48%)

Effect size
(95% CI)
−0.15 (−0.34 to 0.04)

1.6 (0.4-7.1)
1.6 (0.6-4.8)

.11

.54
.39

Abbreviations: CI, confidence interval, Nmiss, the number of missing; ORSDS, Opioid-Related Symptom Distress Scale; PACU, postanesthesia care unit; POD,
postoperative day; QL, quadratus lumborum; QoR-15, quality of recovery-15.
a
Significance level for each secondary outcome is P < .01, adjusted for multiple comparisons on 5 outcomes (ie, .05 of 5, Bonferroni correction). Correspondingly,
99% CIs were reported.
b
Continuous outcome summarized as mean ± standard deviation. Estimated difference between QL versus epidural group was estimated from a linear regression
model. ORSDS is a 4-point scale measured on POD 1–3. The score on each day and the average score over 3 d were summarized as mean ± standard deviation.
c
Categorical outcome is summarized as N (%). The estimated odds ratio of having any antiemetic medication was reported as the effect size.
d
Patient global assessment, summarized as N (%). P was from Wilcoxon test.
e
Significance level for safety and quality outcomes is P < .05, not adjusted for multiple comparisons.

outflow to gastrointestinal tract (T5-T12), resulting in an unopposed parasympathetic tone, leading
to gut hyperperistalsis and accompanying nausea.
Continuous nerve blocks, on the other hand, results
in less sympathectomy and have an opioid-sparing
effect—thus potentially reducing postoperative nausea and vomiting via both mechanisms. Nonetheless,
nausea and vomiting were nonsignificant in our
cohort, with the caveat that our trial was too small
to evaluate this outcome. While the overall outcomes
were in favor of epidural block in open nephrectomy,
interfascial blocks such as QL block may be an alternative in patients where adverse effects of sympathectomy such as hypotension outweigh the overall
benefits of epidural block.
Our trial was assessor-blinded, but patients knew
their group allocations and may have believed that
one modality or the other was preferable, resulting
in biased pain assessments. There is no consensus on
the best type, volume, or concentration of local anesthetics for QL blocks. But it is plausible that QL blocks
require larger volumes to spread appropriately in the
relatively large inter-muscle plane. Results may therefore have differed if we injected more local anesthetic
for the plane block. In our study, we used different
local anesthetics and concentration in the 2 randomized groups; 0.2% ropivacaine (QL block) versus
0.1% bupivacaine (epidural block), might influence
1144   
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analgesia. The comparative potency ratio of mean
effective dose of ropivacaine and bupivacaine previously noted to be 75%.25 Other factors, importantly
the vascularity of interfascial spaces and systemic
absorption might influence the resulted analgesia.
In summary, we were unable to show that subcostal
anterior QL block are noninferior to epidural analgesia in terms of pain score and opioid consumption. No
evidence for a difference in pain scores was observed.
However, patients randomized to QL block required
more than twice as much opioid over the initial 3 postoperative days. Nonetheless, the quality of recovery
and hospital lengths of stay were comparable with each
approach. The efficacy of subcostal QL block should
be rigorously investigated in specific surgical settings
before widespread adoption. E
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